← FDA Drug Approvals (Drugs@FDA)
SUMATRIPTAN SUCCINATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: ONESOURCE SPECIALTY · Approved 2024-11-21
Drug application
- FDA Application #
ANDA215651- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- SUMATRIPTAN SUCCINATE
- Generic name
- SUMATRIPTAN
- Active ingredients
- SUMATRIPTAN SUCCINATE
- Dosage form
- INJECTABLE
- Route
- SUBCUTANEOUS
- Marketing status
- Prescription
- Sponsor
- ONESOURCE SPECIALTY
- Manufacturer
- ONESOURCE SPECIALTY PHARMA LIMITED
- First approval
- 2024-11-21
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown